UNM

What Every Investor Must Know About UNM Stock

We've been asking ourselves recently if the market has placed a fair valuation on Unum. Let's dive into some of the fundamental values of this mid-cap Finance company to determine if there might be an opportunity here for value-minded investors.

Unum Is Potentially Undervalued and Trades Below Its Graham Number:

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 14.34 and an average price to book (P/B) ratio of 1.57. In contrast, Unum has a trailing 12 month P/E ratio of 6.4 and a P/B ratio of 0.98.

When we divideUnum's P/E ratio by its expected five-year EPS growth rate, we obtain a PEG ratio of 0.74, which indicates that the market is undervaluing the company's projected growth (a PEG ratio of 1 indicates a fairly valued company). Your analysis of the stock shouldn't end here. Rather, a good PEG ratio should alert you that it may be worthwhile to take a closer look at the stock.

The Business Runs With Low Leverage Levels:

2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue (MM) $11,999 $13,162 $12,014 $11,991
Interest Income (MM) -$177 -$188 -$185 -$188
Net Margins 9.17% 6.02% 6.86% 10.96%
Net Income (MM) $1,100 $793 $824 $1,314
Depreciation & Amort. (MM) -$110 -$114 -$120 -$110
Earnings Per Share $5.24 $3.89 $4.02 $7.12
EPS Growth n/a -25.76% 3.34% 77.11%
Diluted Shares (MM) 210 204 205 197
Free Cash Flow (MM) $1,591 $478 $1,277 $1,316
Capital Expenditures (MM) -$151 -$119 -$110 -$102
Long Term Debt (MM) $3,327 $3,346 $3,442 $3,430
Net Debt / EBITDA 2.18 2.49 n/a 1.72

Unum has low leverage, positive EPS growth, and consistent free cash flow. Furthermore, Unum has stable revenues and decreasing reinvestment in the business and decent net margins with a stable trend.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS